Published in Gene Therapy Weekly, February 22nd, 2007
The integrated products allow users to analyze genomics data, including gene expression and proteomics, more quickly and accurately in Spotfire DecisionSite, and launch MetaCore to perform pathway and network analysis. DecisionSite users can also automatically upload chemical compounds into MetaCore and MetaDrug in order to study their biological effects, including mode of action and potential toxicity. The analyzed data can be sent back to DecisionSite, allowing the user to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.